Recurrence- and progression-free survival in intermediate-risk non-muscle-invasive bladder cancer: the impact of conditional evaluation and subclassification.
Yuki KohadaTetsutaro HayashiRyan S HsiKazuma YukihiroKazuhiro SentaniKeisuke GotoShogo InoueShinya OharaJun TeisimaMitsuru KajiwaraTakashi NishisakaWataru YasuiPeter C BlackAkio MatsubaraPublished in: BJU international (2020)
Conditional survival analyses of patients with IR NMIBC demonstrate that RFS changes over time, while PFS does not change. These data support distinct surveillance protocols based on the subclassification of IR NMIBC.